Blue Crest Capital Management LTD Elanco Animal Health Inc Transaction History

Blue Crest Capital Management LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$27.74 - $34.09 $1.57 Million - $1.93 Million	-56,479 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$29.2 - $36.72 $631,508 - $794,143	21,627 Added 62.05%	56,479 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$28.76 - $35.98 $1 Million - $1.25 Million	34,852 New	34,852 $1.21 Million
Q2 2019 Aug 14, 2019	SELL	$31.11 - $34.79 $74.5 Million - $83.3 Million	-2,395,203 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$29.0 - $32.83 $69.1 Million - $78.3 Million	2,383,734 Added 20784.15%	2,395,203 $76.8 Million
Q4 2018 Feb 14, 2019	SELL	$29.63 - $34.5 $5.81 Million - $6.76 Million	-196,085 Reduced 94.47%	11,469 $362,000
Q3 2018 Nov 14, 2018	BUY	$34.1 - $36.19 $7.08 Million - $7.51 Million	207,554 New	207,554 $7.24 Million

437

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

Stay updated on Blue Crest Capital Management LTD with notifications on news.